Clinical

 and joined the MJH Life Sciences team in December 2019. She graduated from Youngstown State University in 2019 with a bachelor's degree in journalism and a minor in political science. Prior to graduating, Morgan worked as the editor-in-chief of her college newspaper. She went on to work as an assignment editor at a broadcast news station in Youngstown, Ohio before joining 

Articles

If approved, ibrexafungerp would be the first and only approved therapy for both the treatment of vulvovaginal candidiasis (VVC) and the prevention of recurrent vulvovaginal candidiasis (RVVC).

FDA grants ibrexafungerp sNDA priority review for RVVC

This decision by the US Food and Drug Administration marks the first approved treatment for pediatric lupus nephritis.

FDA approves belimumab for treatment of pediatric lupus nephritis

What we know about monkeypox in pregnancy, including treatment recommendations, vaccination, and postpartum care.

Clinical considerations for monkeypox in pregnancy

VIVUS LLC announced the US Food and Drug Administration's approval of QSYMIA (phentermine and topiramate extended-release capsules) for the treatment of obesity in adolescents ages 12 to 17 years.

QSYMIA approved by FDA for treatment of obesity in adolescents

The approval represents an adjunctive therapy option for pediatric patients older than age 16, as well as adults.

First, only zonisamide oral suspension for treatment of partial seizures approved by FDA

If approved, trofinetide has the potential to be a new treatment for Rett syndrome in pediatric and adult patients 2 years and older.

Acadia submits NDA to FDA for trofinetide for treatment of Rett syndrome

Opzelura (ruxolitinib) cream is the first and only FDA-approved treatment for adult and pediatric patients 12 years of age or older with vitiligo.

FDA approves ruxolitinib cream 1.5% to treat nonsegmental vitiligo

Nonstimulant drugs and even nonmedication options are available for use.



Quick look: The newest drugs for ADHD

Cynthia J. Trickett, PA-C, MPAS, discusses the personal and clinical effects of atopic dermatitis in adult and pediatric patients at the 2022 Maui Dermatology Conference for PAs & NPs.

How dupilumab improves AD in pediatric, adult patients

Ruling comes in cases of physicians serving in prison for convictions over prescription drugs.

Drug Pipeline News